A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
GPCRs are seven-transmembrane proteins that activate intracellular signaling via G-proteins. Neurotransmitter binding triggers GDP-GTP exchange, releasing Gα and Gβγ subunits that modulate adenylyl cyclase, phospholipase C, and ion channels. GPCR signaling is slower (seconds) than ionotropic receptors but longer-lasting and modulates neuronal excitability and gene expression.
Map signaling cascades from receptor to targets. Measure second messengers (cAMP, IP3) in response to GPCR activation.
All neurotransmitter effects are fast and direct—GPCRs enable neuromodulation. G-proteins are simple switches—they have complex kinetics.
You already understand that synaptic transmission involves neurotransmitter release and receptor activation, and you have encountered second messenger systems like cAMP and IP₃, as well as protein kinase cascades. G-protein coupled receptors (GPCRs) are the molecular machinery that connects neurotransmitter binding at the cell surface to those intracellular signaling pathways. They are the largest family of membrane receptors in the human genome — over 800 genes — and the target of roughly one-third of all approved drugs. In the nervous system, GPCRs are what make neuromodulation possible.
The architecture of a GPCR is distinctive: a single polypeptide chain that threads back and forth across the membrane seven times, creating seven transmembrane helices with the neurotransmitter-binding site on the extracellular face and the G-protein coupling site on the intracellular face. When a neurotransmitter binds, the receptor changes shape, and this conformational shift is transmitted through the membrane to the intracellular side. There, the receptor acts as a guanine nucleotide exchange factor (GEF) — it catalyzes the swap of GDP for GTP on the Gα subunit of a heterotrimeric G-protein. This exchange causes the G-protein to split into an active Gα-GTP and a Gβγ dimer, both of which go on to regulate downstream effectors. The signal terminates when Gα hydrolyzes its GTP back to GDP (an intrinsic GTPase activity) and reassociates with Gβγ, returning the system to its resting state.
The beauty of the system is its combinatorial flexibility. Different Gα subtypes activate different effector pathways: Gαs stimulates adenylyl cyclase, raising cAMP levels and activating protein kinase A (PKA); Gαi inhibits adenylyl cyclase, lowering cAMP; Gαq activates phospholipase C (PLC), which cleaves PIP₂ into IP₃ and DAG, releasing calcium from internal stores and activating protein kinase C (PKC). The Gβγ dimer, once considered inert, directly modulates ion channels — for example, opening G-protein-activated inwardly rectifying potassium channels (GIRKs) that hyperpolarize the cell. This means that a single neurotransmitter, acting through different GPCR subtypes coupled to different G-proteins, can produce opposing effects in different neurons. Dopamine excites some neurons via D1 receptors (Gαs-coupled) and inhibits others via D2 receptors (Gαi-coupled).
Compared to ionotropic receptors that open in microseconds and close in milliseconds, GPCR signaling operates on a timescale of hundreds of milliseconds to minutes. This slowness is the point. GPCRs do not carry the fast, point-to-point signals that drive moment-to-moment neural computation — that is the job of ionotropic glutamate and GABA receptors. Instead, GPCRs set the gain of neural circuits: they modulate how excitable a neuron is, how readily it releases neurotransmitter, how strongly its synapses potentiate, and which genes it transcribes. This is neuromodulation in its purest form. When you feel the sustained shift in mood from serotonin, the motivational drive from dopamine, or the heightened vigilance from norepinephrine, you are experiencing the downstream consequences of GPCR activation cascading through second messenger pathways and reshaping neural circuit dynamics over seconds to hours.